At present, all over the world, about one hundred thousand uraemic patients, which is about 15 precent of the total dialysis population are accepting peritoneal dialysis treatment.
腹膜透是通过腹膜这层天然的生物膜,腹腔中的腹透液和腹膜
细血管内的血液之间进行水和溶质转运与交换的过程。目前全世界约有10万名终末期透
患者接受腹膜透
治疗,约占透
总数的15%。